MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7

다국어 초록 (Multilingual Abstract)

Background MicroRNAs (miRNAs) have been reported to play important roles in regulating natural killer (NK) cell cytotoxicity to cancer cells.
Objective This study aimed to investigate the effects and potential mechanism of miR-30c in regulating NK cell cytotoxicity to lung cancer cells.
Methods Primary NK cells were derived from the peripheral blood of lung cancer and normal participants. Exosomes were isolated and validated via transmission electron microscopy and nanoparticle tracking analysis. The levels of miR-30c, polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) and proteins in PI3K/AKT pathway were determined using quantitative real-time polymerase chain reaction or western blot. Tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ) levels and the cytotoxicity of effector NK cells to target lung cancer cells were measured via enzyme linked immunosorbent assay, cell apoptosis or xenograft experiments. The relationship between miR-30c and GALNT7 was analyzed by luciferase activity, RNA pull-down and RNA immunoprecipitation assays. And a xenograft mice model was established to verify the effect of miR-30c in regulating NK cell cytotoxicity to lung cancer cells in vivo.
Results NK cell-derived exosomes carrying miR-30c, and miR-30c level was significantly downregulated in primary NK cells of lung cancer patients. MiR-30c overexpression promoted TNF-α and IFN-γ secretion and enhanced the cytotoxicity of interleukin 2 (IL-2)-treated NK cells to lung cancer cells, while knockdown of miR-30c played an opposite effect in regulating the cytotoxicity of NK cells to lung cancer cells. GALNT7 was a target of miR-30c and was negatively regulated by miR-30c. Besides, miR-30c targeted GALNT7 to exert its function in regulating NK cell cytotoxicity. Furthermore, GALNT7 prompted the activation of PI3K/AKT pathway in NK cells. Additionally, miR-30c overexpression enhanced NK cell cytotoxicity to lung cancer cells and inhibited tumor growth in vivo.
Conclusion miR-30c enhanced NK cell cytotoxicity to lung cancer cells via decreasing GALNT7 and inactivating the PI3K/AKT pathway, suggesting that regulating miR-30c expression maybe a promising approach for enhancing NK cell-based antitumor therapies.

참고문헌 (Reference)

• 1 Gong J, "miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1" 103 : 645-652, 2012
• 2 Wang Y, "miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway" 21 : 618-, 2021
• 3 Zhang LL, "miR-24 inhibited the killing effect of natural killer cells to colorectal cancer cells by downregulating Paxillin" 101 : 257-263, 2018
• 4 Cao Q, "miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway" 20 : 117-, 2020
• 5 Xia C, "Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells" 875 : 173057-, 2020
• 6 Shi P, "Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway" 14 : 370-, 2014
• 7 McDonnell AM, "Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation" 1 : 840-846, 2012
• 8 Leong JW, "Transcriptional and post-transcriptional regulation of NK cell development and function" 177 : 60-69, 2017
• 9 Khong A, "The use of agonistic anti-CD40 therapy in treatments for cancer" 31 : 246-266, 2012
• 10 Xu SJ, "The role of miRNAs in immune cell development, immune cell activation, and tumor immunity : with a focus on macrophages and natural killer cells" 8 : 1-20, 2019
• 11 Ingenito F, "The role of exo-miRNAs in cancer : a focus on therapeutic and diagnostic applications" 20 : 1-8, 2019
• 12 Muenst S, "The immune system and cancer evasion strategies : therapeutic concepts" 279 : 541-562, 2016
• 13 Javadinia SA, "The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs : a novel marker for prognosis, and a possible target for immunotherapy" 24 : 4646-4651, 2018
• 14 Jin F, "The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility" 16 : 38-54, 2019
• 15 Alfarra H, "Targeting NK cell inhibitory receptors for precision multiple myeloma immunotherapy" 11 : 575609-, 2020
• 16 Aktaş ON, "Role of natural killer cells in lung cancer" 144 : 997-1003, 2018
• 17 Cortez MA, "Role of miRNAs in immune responses and immunotherapy in cancer" 58 : 244-253, 2019
• 18 Beavis PA, "Reprogramming the tumor microenvironment to enhance adoptive cellular therapy" 28 : 64-72, 2016
• 19 O’Donnell JS, "PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux" 48 : 91-103, 2018
• 20 Song X, "Overexpression of PTPRN promotes metastasis of lung adenocarcinoma and suppresses NK cell cytotoxicity" 9 : 622018-, 2021
• 21 Liu P, "Natural killer cells in liver disease and hepatocellular carcinoma and the NK cell-based immunotherapy" 2018 : 1206737-, 2018
• 22 Abel AM, "Natural killer cells : development, maturation, and clinical utilization" 9 : 1869-, 2018
• 23 Hammer Q, "Natural killer cell specificity for viral infections" 19 : 800-808, 2018
• 24 Wu H, "MicroRNA-30e functions as a tumor suppressor in cervical carcinoma cells through targeting GALNT7" 10 : 876-885, 2017
• 25 Ma Y, "MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D" 151 : 174-181, 2016
• 26 Ma T, "MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma" 98 : 680-686, 2018
• 27 Zhong K, "MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18" 14 : 703-, 2014
• 28 Wu SJ, "MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma" 37 : 18-, 2018
• 29 Zhou X, "MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription 3" 523 : 481-486, 2020
• 30 Iqbal MA, "MicroRNA in lung cancer : role, mechanisms, pathways and therapeutic relevance" 70 : 3-20, 2019
• 31 Pan C, "MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer" 18 : 52-, 2018
• 32 Quanjun Yang ; Jingjing Li ; Yili Hu ; Xiaofei Tang ; Lili Yu ; Lihua Dong ; Diandian Chen, "MiR-218-5p Suppresses the Killing Effect of Natural Killer Cell to Lung Adenocarcinoma by Targeting SHMT1" 연세대학교의과대학 60 (60): 500-508, 2019
• 33 Li Y, "Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression" 11 : 89-, 2018
• 34 Wang JB, "Long non-coding RNA TP73-AS1 contributes to glioma tumorigenesis by sponging the miR-103a/GALNT7 pathway" 1741 : 146886-, 2020
• 35 Liu Y, "Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers" 36 : 6143-6153, 2017
• 36 Steven A, "Immunotherapy for lung cancer" 21 : 821-833, 2016
• 37 Iams WT, "Immunotherapeutic approaches for small-cell lung cancer" 17 : 300-312, 2020
• 38 Eichmüller SB, "Immune modulatory microRNAs involved in tumor attack and tumor immune escape" 109 : 1-14, 2017
• 39 Ali AK, "IL-15-PI3K-AKT-mTOR : a critical pathway in the life journey of natural killer cells" 6 : 355-, 2015
• 40 Hua S, "High expression of GALNT7 promotes invasion and proliferation of glioma cells" 16 : 6307-6314, 2018
• 41 Nie GH, "GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma" 37 : 4559-4567, 2016
• 42 Myers JA, "Exploring the NK cell platform for cancer immunotherapy" 18 : 85-100, 2021
• 43 Zhu L, "Exosomes derived from natural killer cells exert therapeutic effect in melanoma" 7 : 2732-2745, 2017
• 44 Zhao GS, "Evaluation of radioactive(125)I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique : efficacy and safety" 20 : 718-, 2020
• 45 Yang S, "Emerging therapies for small cell lung cancer" 12 : 47-, 2019
• 46 Cong J, "Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression" 28 : 243-255, 2018
• 47 Lai YH, "Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer" 36 : 92-, 2017
• 48 Siegel RL, "Cancer statistics, 2018" 68 : 7-30, 2018
• 49 Zhang D, "A potential role of microvesicle-containing miR-223/142 in lung inflammation" 74 : 865-874, 2019